hydroxychloroquine has been researched along with gamma-aminobutyric acid in 2 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayliss, SJ; Berk, DR; Lu, D; Miller, A; Scarlett, D; Wippold, FJ | 1 |
| Alvarado-Franco, NL; Femat-Roldan, G; Garza-Alpirez, A; Gonzalez-Marques, C; Martinez-Ramirez, D; Olguín-Ramírez, LA | 1 |
2 other study(ies) available for hydroxychloroquine and gamma-aminobutyric acid
| Article | Year |
|---|---|
Osseous metaplasia late in the course of nephrogenic systemic fibrosis.
Topics: Adult; Analgesics; Calcinosis; Disease Progression; Female; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Metaplasia; Nephrogenic Fibrosing Dermopathy; Pregabalin; Quinacrine; Skin; Thalidomide; Treatment Outcome | 2010 |
Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome.
Topics: Aged; Amines; Anticonvulsants; Athetosis; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Movement Disorders; Muscarinic Agonists; Pilocarpine; Sjogren's Syndrome | 2018 |